Discover

SNGX
Soligenix, Inc.
0.36
2 x 0.25
1 x 1.00
bid
ask
+
0.02
4.90%
2 @ 05:36 PM
0.36 -0.00 (0.30%)
Ytd-72.87%
1y-79.69%
0.35
day range
0.37
0.28
52 week range
1.79
Open0.35Prev Close0.35Low0.35High0.37Mkt Cap7.91M
Vol114.52KAvg Vol249.87KEPS-0.79P/EN/AForward P/E-0.56
Beta1.99Short Ratio1.06Inst. Own2.63%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1150-d Avg0.38200-d Avg0.761yr Est22.50

SNGX News

Contrasting Zura Bio (NASDAQ:ZURA) and Soligenix (NASDAQ:SNGX)
defenseworld.net
Contrasting Zura Bio (NASDAQ:ZURA) and Soligenix (NASDAQ:SNGX)

Soligenix (NASDAQ: SNGX - Get Free Report) and Zura Bio (NASDAQ: ZURA - Get Free Report) are both sm

benzinga.com
Soligenix Q2 EPS $(0.12) Beats $(0.15) Estimate

Soligenix (NASDAQ:SNGX) reported quarterly losses of $(0.12) per share which beat the analyst consen

Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results
prnewswire.com
Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results

PRINCETON, N.J., Aug. 7, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Compa

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 41.1% to $0.09 during Frida

From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak
feeds.newsfilecorp.com
From Vaccines to Therapeutics; How Biotech Is Addressing the Ebola Outbreak

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 26, 2026) - Investorideas.co

benzinga.com
Soligenix To Apply For Bundibugyo Ebola Vaccine Development Funding

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company fo

Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine
prnewswire.com
Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine

Thermostability, immunogenicity and efficacy data against related viruses provides firm starting poi

benzinga.com
U.S. State Dept Announces Nearly $38M In Additional Funding Toward The Department's Ongoing Ebola Re

https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why Tetra Technologies Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Tetra Technologies Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket

Tetra Technologies Inc. (NYSE: TTI) shares fell 15.06% in pre-market trading after announcing a $100

Crude Oil Falls Over 5%; Dycom Industries Shares Surge Following Q1 Results
benzinga.com
Crude Oil Falls Over 5%; Dycom Industries Shares Surge Following Q1 Results

U.S. stocks traded mixed, Nasdaq down 0.3%. Dow up 0.59%, S&P 500 down 0.09%. Consumer discretio

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Dow Jumps Over 300 Points; Dick's Sporting Shares Fall After Q1 Results
benzinga.com
Dow Jumps Over 300 Points; Dick's Sporting Shares Fall After Q1 Results

US stocks mixed, Dow up 300 pts. Dow up 0.64%, NASDAQ down 0.34%. Consumer discretionary up 1.7%, en

Why Semtech Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Semtech Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket

Semtech Corp (SMTC) reported strong Q1 financial results, beating analysts' estimates. Shares ro

Soligenix (SNGX) Stock Soars 72% On ThermoVax Platform Promise Amid Ebola Outbreak Caused By Bundibugyo Virus
benzinga.com
Soligenix (SNGX) Stock Soars 72% On ThermoVax Platform Promise Amid Ebola Outbreak Caused By Bundibu

Soligenix shares surged 72.32% in after-hours trading following rapid Bundibugyo virus vaccine devel

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo
prnewswire.com
Suitability of Vaccine Platform for Bundibugyo Virus, Cause of the Ebola Outbreak in Congo

Thermostability, immunogenicity and efficacy data against related virusesmay provide rapid starting

benzinga.com
U.S. CDC Says Will Enhance Screening And Monitoring Of Travelers Arriving From Areas Affected By Ebo

https://www.cdc.gov/ebola/situation-summary/index.html

benzinga.com
Soligenix Q1 EPS $(0.28), Inline

Soligenix (NASDAQ:SNGX) reported quarterly losses of $(0.28) per share which met the analyst consens

Soligenix Announces Recent Updates and First Quarter 2026 Financial Results
prnewswire.com
Soligenix Announces Recent Updates and First Quarter 2026 Financial Results

PRINCETON, N.J., May 8, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Compan

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

Crude Oil Gains Over 3%; General Motors Earnings Top Views
benzinga.com
Crude Oil Gains Over 3%; General Motors Earnings Top Views

US stocks down, NASDAQ falls over 1% on Tuesday. Dow up 0.20%, NASDAQ down 1.24%, S&P 500 down 0

Why Is Soligenix Stock Sinking Tuesday?
benzinga.com
Why Is Soligenix Stock Sinking Tuesday?

Soligenix ends Phase 3 FLASH2 study for HyBryte. CEO cites unanticipated results. See how this impac

Dow Gains 150 Points; Coca-Cola Posts Upbeat Earnings
benzinga.com
Dow Gains 150 Points; Coca-Cola Posts Upbeat Earnings

US stocks mixed with Dow up 150 pts. Dow up 0.27%, NASDAQ down 1.06%, S&P 500 down 0.52%. Energy

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga.com
The Data Monitoring Committee Recommends Soligenix To Halt Phase 3 FLASH2 Trial Of HyBryte (Syntheti

Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company foc

Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment of Cutaneous T-Cell Lymphoma
prnewswire.com
Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment o

PRINCETON, N.J., April 28, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Com

Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy
prnewswire.com
Positive Clinical Results from HyBryte™ Comparative Study Evaluating HyBryte™ Against Valchlor® in t

HyBryte™ demonstrates more rapid and robust treatment response compared toValchlor ® during 12-week

Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results
prnewswire.com
Soligenix Announces Recent Accomplishments and Year End 2025 Financial Results

Upcoming high-impact milestones include interim analysis in Q2 2026 and top-line results in H2 2026

Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease
prnewswire.com
Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment

PRINCETON, N.J., March 26, 2026 /PRNewswire/ --Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Comp

HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026
prnewswire.com
HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026

Highlighting Positive Results in Comparison to Valchlor ® and in Real-World Use PRINCETON, N.J., Mar

IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Dr. Christopher Schaber, CEO of Soligenix Inc.
globenewswire.com
IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Dr. Christopher Schab

AUSTIN, Texas, March 19, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organ

Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"
prnewswire.com
Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"

PRINCETON, N.J., March 19, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Com

Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency
prnewswire.com
Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines

PRINCETON, N.J., March 10, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Com

Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet's Disease
prnewswire.com
Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Dru

PRINCETON, N.J., Feb. 26, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Comp

Soligenix to Present at BIO Investment & Growth Summit
prnewswire.com
Soligenix to Present at BIO Investment & Growth Summit

PRINCETON, N.J., Feb. 24, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Comp

Soligenix Details Recent Progress and Upcoming Milestones
prnewswire.com
Soligenix Details Recent Progress and Upcoming Milestones

PRINCETON, N.J., Feb. 12, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Comp

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Short Interest in Soligenix Inc. (NASDAQ:SNGX) Decreases By 12.5%
defenseworld.net
Short Interest in Soligenix Inc. (NASDAQ:SNGX) Decreases By 12.5%

Soligenix Inc. (NASDAQ: SNGX - Get Free Report) was the target of a significant drop in short intere

Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçet's Disease Published in Rheumatology (Oxford)
prnewswire.com
Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçet's Disease Publish

Study results support advancing SGX945 in this difficult-to-treat orphan disease Results suggest pot

Soligenix Psoriasis Trial Extension Shows Better Outcomes With New Gel
benzinga.com
Soligenix Psoriasis Trial Extension Shows Better Outcomes With New Gel

Soligenix, Inc. (NASDAQ: SNGX) on Wednesday announced extended results of its ongoing Phase 2a trial

benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday&#

benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday&#39

benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

5 Healthcare Stocks On Fire This Week
benzinga.com
5 Healthcare Stocks On Fire This Week

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling brea

Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarke

benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session